Trials / Completed
CompletedNCT01815073
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
A Study to Evaluate the Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 497 (actual)
- Sponsor
- Changchun Keygen Biological Products Co., Ltd. · Academic / Other
- Sex
- All
- Age
- 1 Year – 3 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to observe the occurrence of adverse events and seroconversion rate, geometric mean titres (GMTs) of live attenuated varicella vaccine，live attenuated JE vaccine and live attenuated varicella vaccine combined with live attenuated JE vaccine, respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine | |
| BIOLOGICAL | Live Attenuated Varicella Vaccine | |
| BIOLOGICAL | live attenuated JE vaccine |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-03-20
- Last updated
- 2014-02-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01815073. Inclusion in this directory is not an endorsement.